Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Covington
Argus Health
Daiichi Sankyo
Queensland Health
Novartis
US Army
Julphar
Harvard Business School
Dow

Generated: January 18, 2018

DrugPatentWatch Database Preview

Heparin sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for heparin sodium and what is the scope of heparin sodium freedom to operate?

Heparin sodium
is the generic ingredient in thirty-eight branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Akorn, Chamberlin Parenterl, Dell Labs, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira Inc, Lilly, Organon Usa Inc, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs, Watson Labs Inc, West-ward Pharms Int, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, and 3M, and is included in seventy-five NDAs. Additional information is available in the individual branded drug profile pages.

There are seventy-seven drug master file entries for heparin sodium. Fourteen suppliers are listed for this compound.
Pharmacology for heparin sodium

US Patents and Regulatory Information for heparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 018609-001 Apr 28, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharm Spec HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017780-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017064-019 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019805-001 Jan 25, 1989 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira HEPARIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 005264-014 Apr 7, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017064-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dell Labs HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017540-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira PANHEPRIN heparin sodium INJECTABLE;INJECTION 005264-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019952-005 Jul 20, 1992 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Organon Usa Inc LIQUAEMIN SODIUM heparin sodium INJECTABLE;INJECTION 000552-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
AstraZeneca
Moodys
US Army
Mallinckrodt
Cantor Fitzgerald
Novartis
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot